Activation of NF-κβ has been shown to promote survival in estrogen receptor- (ER-) negative and ErbB2-positive breast tumors, while selective inhibition of this transcription factor results in apoptosis of breast cancer cell lines [6]. Here, ESR1 is linked to breast neoplasm.